Global Respiratory Disease Diagnostics Market 2023-2029

March 2023 | 78 pages | ID: G2457A3AD2DCEN
Gen Consulting Company

Abstracts

The global respiratory disease diagnostics market is likely to register a CAGR of over 7.7% with an incremental growth of USD 4.4 billion during the forecast period 2023-2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global respiratory disease diagnostics market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, test type, disease, end user, and region. The global market for respiratory disease diagnostics can be segmented by product: assays and reagents, instruments and devices, services and software. In 2022, the instruments and devices segment made up the largest share of revenue generated by the respiratory disease diagnostics market. Respiratory disease diagnostics market is further segmented by test type: imaging tests, in-vitro diagnostics tests, mechanical tests. The imaging tests segment was the largest contributor to the global respiratory disease diagnostics market in 2022. Based on disease, the respiratory disease diagnostics market is segmented into: asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, others. The COPD segment is estimated to account for the largest share of the global respiratory disease diagnostics market. On the basis of end user, the respiratory disease diagnostics market also can be divided into: hospitals and clinics, reference laboratories, others. The hospitals and clinics segment held the largest share of the global respiratory disease diagnostics market in 2022 and is anticipated to hold its share during the forecast period. Respiratory disease diagnostics market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation

By product: assays and reagents, instruments and devices, services and software

By test type: imaging tests, in-vitro diagnostics tests, mechanical tests

By disease: asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, others

By end user: hospitals and clinics, reference laboratories, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., CAREstream Medical Ltd., COSMED S.r.l, F. Hoffmann- La Roche AG, Koninklijke Philips N.V., Medtronic plc, MGC Diagnostics Corporation, SDI Diagnostics Inc., Seegene, Inc., Thermo Fisher Scientific Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report

• To analyze and forecast the market size of the global respiratory disease diagnostics market.
• To classify and forecast the global respiratory disease diagnostics market based on product, test type, disease, end user, region.
• To identify drivers and challenges for the global respiratory disease diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global respiratory disease diagnostics market.
• To identify and analyze the profile of leading players operating in the global respiratory disease diagnostics market.

Why Choose This Report

• Gain a reliable outlook of the global respiratory disease diagnostics market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Assays and reagents
Instruments and devices
Services and software

PART 6. MARKET BREAKDOWN BY TEST TYPE

Imaging tests
In-vitro diagnostics tests
Mechanical tests

PART 7. MARKET BREAKDOWN BY DISEASE

Asthma
Chronic obstructive pulmonary disease (COPD)
Tuberculosis
Others

PART 8. MARKET BREAKDOWN BY END USER

Hospitals and clinics
Reference laboratories
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Abbott Laboratories
Becton, Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
CAREstream Medical Ltd.
COSMED S.r.l
F. Hoffmann- La Roche AG
Koninklijke Philips N.V.
Medtronic plc
MGC Diagnostics Corporation
SDI Diagnostics Inc.
Seegene, Inc.
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER